Edition:
United States

Minapharm Pharmaceuticals SAE (MIPH.CA)

MIPH.CA on Cairo Stock Exchange

66.01EGP
21 May 2017
Change (% chg)

-- (--)
Prev Close
£66.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
780
52-wk High
£77.41
52-wk Low
£30.00

MIPH.CA

Chart for MIPH.CA

About

Minapharm Pharmaceuticals SAE is an Egypt-based company engaged in the production and distribution of pharmaceutical products. The Company’s production falls into seven lines, namely Gastroenterology, Ophthalmology, Cardiology, Biogenetics, Dermatology, Dermatology, Orthopedic and Miscellaneous products such as betolvex,... (more)
No analyst recommendations are available for MIPH.CA.

Overall

Beta: 0.63
Market Cap(Mil.): £811.49
Shares Outstanding(Mil.): 12.29
Dividend: 4.50
Yield (%): 6.14

Financials

  MIPH.CA Industry Sector
P/E (TTM): 24.63 14.27 17.29
EPS (TTM): 2.68 -- --
ROI: 4.85 -7.68 -5.84
ROE: 3.83 -7.30 -5.23

BRIEF-Minapharm Pharmaceuticals Q1 profit falls

* Q1 net profit EGP 7.7 million versus EGP 29.1 million year ago

May 15 2017

BRIEF-Minapharm Pharmaceuticals Q3 consol profit rises

* Nine-month consol net profit EGP 101.6 million versus EGP 95.9 million year ago

Nov 29 2016

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.